healthcare.digital January 19, 2026
Executive Summary
The enterprise value (EV) to equity value bridge represents the critical calculation that determines what shareholders actually receive in a transaction, the difference between a buyer’s headline offer and the cash distributed to founders and investors. In the European HealthTech and MedTech sectors entering 2026, this bridge calculation has become increasingly complex, driven by structural market shifts including the end of the zero interest rate policy (ZIRP) era, heightened regulatory compliance burdens under MDR/IVDR, refinancing pressures from 2019-2021 vintage debt, and the maturation of the sector from “growth at all costs” to “industrial efficiency.”
This report examines the ten most significant factors affecting the EV to equity value bridge, ranked by their typical financial impact and prevalence in...
Today's Sponsors
Today's Sponsor